Innovative Technology Nanite's AI-driven platform SAYER enables precise and tissue-specific gene delivery, which can be highly appealing to biotech firms seeking advanced genetic therapy solutions and partnerships for delivery vehicle development.
Growing Funding Support Recent seed funding of $6M and a $2M financing round demonstrate strong investor confidence, indicating potential for future collaborations or investment opportunities in Nanite's innovative gene delivery technologies.
Focus on Rare Diseases Nanite is actively developing genetic treatments for conditions like cystic fibrosis and Charcot-Marie-Tooth disease, suggesting opportunities for partnerships with healthcare providers and organizations targeting rare and genetic diseases.
Strategic Collaborations Partnerships with foundations such as the Cystic Fibrosis Foundation and CMT Research Foundation highlight Nanite’s strategic positioning to collaborate with organizations focused on therapeutic development, which could be expanded to pharma and biotech companies.
Market Expansion Potential With a focus on non-viral gene delivery and tissue-specific targeting, Nanite presents a compelling solution for biotech firms exploring next-generation gene therapies, creating opportunities for joint ventures, licensing, or technology licensing arrangements.
$1M$10M
$250M$500M
$25M$50M
$250M$500M
$1B$10B
$25M$50M
$10M$25M
$500M$1BNanite uses 8 technology products and services including Bunny, SQL, Google Cloud, and more. Explore Nanite's tech stack below.
| Nanite Email Formats | Percentage |
| First@nanitebio.com | 38% |
| First.Last@nanitebio.com | 20% |
| First.MiddleLast@nanitebio.com | 4% |
| First@nanitebio.com | 38% |
Biotechnology ResearchUnited States11-50 Employees
Nanite is a next-generation non-viral gene delivery company developing a new class of programmable polymer nanoparticles for a range of modalities and indications. The company’s AI-driven platform, SAYER, combines cutting-edge high-throughput experimental and computational methods to design fit-for-purpose delivery vehicles delivering a broad range of genetic cargoes with tissue specificity.
Company Overview
Funding & FinancialsNanite has raised a total of $1.8M of funding over 3 rounds. Their latest funding round was raised on May 08, 2024 in the amount of $1.8M.
Nanite's revenue is estimated to be in the range of $10M$25M
Funding & FinancialsNanite has raised a total of $1.8M of funding over 3 rounds. Their latest funding round was raised on May 08, 2024 in the amount of $1.8M.
Nanite's revenue is estimated to be in the range of $10M$25M
1-888-653-2347 
support@leadiq.com